4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001584759-25-000004
Director acquired 32,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heyman Richard A. Director | 2025-10-03 | Option exercise | +31,353 | $1.60 | $50,165 | 43,853 | D |
| Heyman Richard A. Director | 2025-10-03 | Option exercise | +1,447 | $3.75 | $5,426 | 45,300 | D |
| Derivatives | |||||||
| Heyman Richard A. Director | 2025-10-03 | Option exercise · Stock Option (right to buy) | −13,228 | 33,700 | D | ||
| Heyman Richard A. Director | 2025-10-03 | Option exercise · Stock Option (right to buy) | −18,125 | 0 | D | ||
| Heyman Richard A. Director | 2025-10-03 | Option exercise · Stock Option (right to buy) | −1,447 | 52,253 | D | ||
Loading xslF345X05/form4-10032025_111055.xml…